PUBLICATIONS

Selecting the right linguists to translate life science content is a critical process due to the specialized nature of the field and the fact that the market is highly regulated. Documents may comprise a mixture of complex scientific data, medical terminology, and technical language. Inaccurate translations in clinical trial documentation, patient information leaflets, or drug labels can jeopardize patient safety, leading to the improper use of medication or devices. It is vital to ensure accuracy, compliance, cultural sensitivity, and clear communication, all of which are essential for the safety, effectiveness, and success of life science products and services.

Xiaoxiao Hu is a project manager in the Global Localization Department and heads up our office in China. We spoke to her about her professional journey as part of our company, her approach to work, China’s  unique culture, and a few other interesting topics. We hope you enjoy reading the interview!

We are thrilled to announce the launch of our latest project, the AI Taskforce Initiative. As a pioneer in the Translation and Localization industry, Janus Worldwide is driven by innovation, excellence, and the desire to make a difference. This new initiative aligns perfectly with the mission to provide our clients with the best possible translation and localization services in terms of quality, price, and speed.

Pharmaceutical companies face numerous translation challenges, especially when it comes to translating medical and scientific documents. They must comply with the various regulatory requirements across different countries for clinical trials, marketing authorization applications, and product labeling.

The world is becoming increasingly interconnected, and the demand for translating and adapting multimedia content in different languages and cultures is pivotal. Artificial Intelligence (AI) is a game-changer in this area, offering tools that can significantly increase efficiency and accuracy.